Hsbc Holdings PLC Nektar Therapeutics Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Hsbc Holdings PLC holds 98,478 shares of NKTR stock, worth $91,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,478
Previous 75,848 29.84%
Holding current value
$91,584
Previous $94,000 36.17%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.11 - $1.48 $25,119 - $33,492
22,630 Added 29.84%
98,478 $128,000
Q2 2023

Aug 11, 2023
SELL
$0.53 - $1.03 $3,103 - $6,031
-5,856 Reduced 7.17%
75,848 $43,000
Q1 2023

May 15, 2023
SELL
$0.64 - $3.15 $18,685 - $91,967
-29,196 Reduced 26.33%
81,704 $57,000
Q4 2022

Feb 14, 2023
BUY
$2.03 - $4.28 $61,372 - $129,397
30,233 Added 37.48%
110,900 $250,000
Q3 2022

Nov 14, 2022
BUY
$3.04 - $5.14 $114,939 - $194,338
37,809 Added 88.22%
80,667 $263,000
Q2 2022

Aug 11, 2022
BUY
$3.17 - $6.17 $66,452 - $129,341
20,963 Added 95.74%
42,858 $162,000
Q1 2022

May 16, 2022
BUY
$4.16 - $13.72 $22,160 - $73,086
5,327 Added 32.15%
21,895 $119,000
Q4 2021

Feb 11, 2022
BUY
$10.83 - $18.41 $179,431 - $305,016
16,568 New
16,568 $223,000
Q3 2021

Nov 12, 2021
SELL
$13.07 - $18.84 $309,915 - $446,734
-23,712 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$16.52 - $20.4 $391,722 - $483,724
23,712 New
23,712 $406,000
Q4 2020

Feb 12, 2021
SELL
$15.77 - $19.03 $304,897 - $367,926
-19,334 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$16.59 - $24.79 $50,549 - $75,535
3,047 Added 18.71%
19,334 $323,000
Q2 2020

Aug 14, 2020
BUY
$16.86 - $23.44 $274,598 - $381,767
16,287 New
16,287 $377,000
Q4 2019

Feb 14, 2020
SELL
$15.87 - $23.12 $1.07 Million - $1.56 Million
-67,643 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$16.91 - $36.27 $142,162 - $304,921
-8,407 Reduced 11.05%
67,643 $1.23 Million
Q2 2019

Aug 13, 2019
BUY
$31.0 - $36.3 $213,249 - $249,707
6,879 Added 9.94%
76,050 $2.71 Million
Q1 2019

May 15, 2019
BUY
$31.58 - $46.35 $616,283 - $904,520
19,515 Added 39.3%
69,171 $2.32 Million
Q4 2018

Feb 13, 2019
SELL
$30.43 - $56.65 $433,931 - $807,829
-14,260 Reduced 22.31%
49,656 $1.63 Million
Q3 2018

Nov 13, 2018
BUY
$46.46 - $68.49 $344,593 - $507,990
7,417 Added 13.13%
63,916 $3.84 Million
Q2 2018

Aug 10, 2018
SELL
$46.25 - $104.45 $4.28 Million - $9.66 Million
-92,461 Reduced 62.07%
56,499 $2.76 Million
Q1 2018

May 11, 2018
BUY
$57.4 - $108.44 $8.55 Million - $16.2 Million
148,960 New
148,960 $15.8 Million

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $174M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email